EX-8.1 7 a2221729zex-8_1.htm EX-8.1

Exhibit 8.1

 

Deloitte

Statsautoriseret Revisionspartnerselskab CVR-no.   33 96 35 56
Weidekampsgade 6

P.O. Box 1600

0900 Copenhagen C

Denmark

 

 

 

Phone
Fax

+45 36 10 20 30
+45 36 10 20 40

October 9, 2014.

www.deloitte.dk

 

Forward Pharma A/S
Østergade 24A, 1

1000 Copenhagen K
Denmark

 

Ladies and Gentleman,

 

Assessment of Section “Taxation – Danish Tax Considerations” of the Prospectus for Forward Pharma A/S

 

As agreed, we are acting as special Danish tax counsel to Forward Pharma A/S, a public limited liability company registered with the Danish Business Authority under company registration number 28865880 (the “Company”), with respect to certain legal matters in connection with the registration statement on Form F-1 (Registration No. 333-198013) (as filed and amended, the “Registration Statement”) filed by the Company on October 9, 2014 with the Securities and Exchange Commission (the “Commission”) registering American Depositary Shares representing 9,523,810 ordinary shares of the Company, DKK 0.10 nominal value per share, under the Securities Act of 1933, as amended (the “Act”). As requested, we have examined the section “Taxation – Danish Tax Considerations” within the Registration Statement in order to assess the accuracy of the information provided in the section.

 

Conclusion

 

Based on our review of the section “Taxation – Danish Tax Considerations” of the Registration Statement, it is our opinion that the information in the section is both accurate and complete.

 

In arriving at our opinion, we have examined and relied upon the Registration Statement and any other documents that in our judgment are necessary or appropriate to enable us to render our opinion.

 

We hereby consent to the filing of this opinion as an exhibit to the Registration Statement and to the use of our name under the caption “Legal Matters” in the Registration Statement. In giving such consent, we do not admit that we are within the category of persons whose consent is required under Section 7 of the Act, or the rules or regulations of the Commission promulgated thereunder.

 

Member of Deloitte Touche Tohmatsu Limited

 



 

Deloitte

Statsautoriseret Revisionspartnerselskab

 

/s/ Erik Banner-Voigt

 

/s/ Jakob Schilder-Knudsen

Erik Banner-Voigt

 

Jakob Schilder-Knudsen

Tax Partner

 

Tax Director

 

2